언어 선택

GPRC5B

GPRC5B 제품 목록

속성
Protein (1)
제품 라이브러리
온라인 (1)
종
Human (1)
태그
His Tag & Flag Tag (1)
마커
Unconjugated (1)

제품 번호	종	발현 시스템	제품 설명	단백질 구조	순도	특성
GPB-H52D7	Human	HEK293	Human GPRC5B Protein, Flag,His Tag (Detergent)

총 수량1

제품 문의

GPRC5B분자 배경

This gene encodes a member of the type 3 G protein-coupled receptor family. Members of this superfamily are characterized by a signature 7-transmembrane domain motif. The encoded protein may modulate insulin secretion and increased protein expression is associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Atacicept	TACI-Ig	Phase 3 Clinical	Zymogenetics Inc	Glomerulonephritis, IGA; Kidney Diseases; Arthritis, Rheumatoid; Multiple Sclerosis; Optic Neuritis; Lupus Nephritis; Urinary Bladder Diseases; Lupus Erythematosus, Systemic	상세
Zigakibart	BION-1301	Phase 3 Clinical	Aduro Biotech Inc	Glomerulonephritis, IGA; Proteinuria; Multiple Myeloma	상세
Povetacicept	ALPN-303; ALPN 30x	Phase 3 Clinical		Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Purpura, Thrombocytopenic, Idiopathic; Myasthenia Gravis; Glomerulonephritis, IGA; Sjogren's Syndrome; Glomerulonephritis, Membranous; Lupus Nephritis; Lupus Erythematosus, Systemic; Anemia, Hemolytic, Autoimmune; Inflammation; Cytopenia; Glomerulonephritis	상세
Sibeprenlimab	VIS-649	Phase 3 Clinical	Visterra Inc	Glomerulonephritis, IGA; Glomerulonephritis	상세
IM-21	IM21; IM-21	Phase 1 Clinical	Beijing Yimiao Medical Technology Co Ltd	Multiple Myeloma	상세
Anti-BCMA CAR T-cell therapy (Actavis/Eugia Pharma)		Phase 1 Clinical	Eugia Pharma Specialities Ltd, Actavis Inc	Multiple Myeloma	상세
anti-TriPRIL CAR T-cell therapy（Massachusetts General Hospital）		Phase 1 Clinical	Massachusetts General Hospital	Multiple Myeloma	상세
AUR-200	AUR-200; AUR200	Phase 1 Clinical	Thunderbolt Pharma Inc	Autoimmune Diseases	상세
RO-7297089	RO-7297089; AFM-26; RG-6296	Phase 1 Clinical	Genentech Inc	Multiple Myeloma	상세
APRIL CAR-T Cell therapy (Yake Biotechnology)		Phase 1 Clinical	Shanghai YaKe Biotechnology Co Ltd	Multiple Myeloma	상세
Anti-BCMA CAR T-cell therapy (Huazhong University of Science and Technology)		Clinical	Huazhong University Of Science And Technology	Multiple Myeloma	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Telitacicept	RCT-18; RC-18; RCT18; RC18	Approved	RemeGen Co Ltd		Mainland China	Lupus Erythematosus, Systemic	RemeGen Co Ltd	2021-03-09	Myasthenia Gravis; Multiple Sclerosis, Relapsing-Remitting; Glomerulonephritis, IGA; Nephrosis; Immunoglobulin G4-Related Disease; Arthritis, Rheumatoid; Sjogren's Syndrome; Multiple Sclerosis; Lupus Nephritis; Neuromyelitis Optica; Lupus Erythematosus, Systemic	상세